Literature DB >> 12471454

On the neuronal/neuroblastic nature of medulloblastomas: a tribute to Pio del Rio Hortega and Moises Polak.

Christos D Katsetos1, Luis Del Valle, Agustin Legido, Jean-Pierre de Chadarévian, Elias Perentes, Sverre J Mörk.   

Abstract

The concept that medulloblastomas represent cerebellar neuroblastic tumours was championed by del Rio Hortega in the 1930s and was critically reappraised in the 1960s by Moises Polak. Whereas the aetiology and molecular pathogenesis of medulloblastomas remain unresolved, there is now compelling evidence in support of a fundamentally neuronal tumour phenotype. Tumour cells express in a differentiation-dependent manner a repertoire of neuronal cytoskeletal, synaptic, and other lineage-associated proteins. Neuronal differentiation is more pronounced in the so-called nodular/desmoplastic medulloblastomas, which are typified by areas of neoplastic neuritogenesis ("pale islands") marked by the co-expression of neuronal marker proteins and neurotrophin receptors TrkA and TrkC, low proliferative indices, and apoptosis. The pale islands contain meshworks of reactive astrocytes as part of mutually inductive tumour-stromal cell interactions. However, overt glial differentiation or gliomatous transformation are uncommon. There is growing evidence to support the hypothesis that distinct subtypes of medulloblastomas may implicate transformed neuroblasts from two separate neuroepithelial sources: (a) the velum medullare for a subset of classic medulloblastomas, and (b) the external granule layer for the nodular/desmoplastic medulloblastomas as well as certain classic medulloblastomas. The nosological position of medulloblastomas is discussed in the context of the so-called embryonal central nervous system tumours with emphasis on the cerebral and cerebellar neuroblastomas. We give credence to the view that the medulloblastoma belongs to a group of central neuronal/neuroblastic tumours and call for a critical re-evaluation of its present taxonomic placement.

Entities:  

Mesh:

Year:  2002        PMID: 12471454     DOI: 10.1007/s00401-002-0618-5

Source DB:  PubMed          Journal:  Acta Neuropathol        ISSN: 0001-6322            Impact factor:   17.088


  8 in total

Review 1.  Medulloblastoma: therapy and biologic considerations.

Authors:  Timothy R Gershon; Orren J Becher
Journal:  Curr Neurol Neurosci Rep       Date:  2006-05       Impact factor: 5.081

2.  Class III beta-tubulin and gamma-tubulin are co-expressed and form complexes in human glioblastoma cells.

Authors:  Christos D Katsetos; Eduarda Dráberová; Barbora Smejkalová; Goutham Reddy; Louise Bertrand; Jean-Pierre de Chadarévian; Agustin Legido; Jonathan Nissanov; Peter W Baas; Pavel Dráber
Journal:  Neurochem Res       Date:  2007-04-04       Impact factor: 3.996

3.  Identification of CD15 as a marker for tumor-propagating cells in a mouse model of medulloblastoma.

Authors:  Tracy-Ann Read; Marie P Fogarty; Shirley L Markant; Roger E McLendon; Zhengzheng Wei; David W Ellison; Phillip G Febbo; Robert J Wechsler-Reya
Journal:  Cancer Cell       Date:  2009-02-03       Impact factor: 31.743

4.  Expression of the neurogenic basic helix-loop-helix transcription factor NEUROG1 identifies a subgroup of medulloblastomas not expressing ATOH1.

Authors:  Ettore Salsano; Laura Croci; Emanuela Maderna; Linda Lupo; Bianca Pollo; Maria Teresa Giordana; G Giacomo Consalez; Gaetano Finocchiaro
Journal:  Neuro Oncol       Date:  2007-05-23       Impact factor: 12.300

5.  Inhibition of ERβ induces resistance to cisplatin by enhancing Rad51-mediated DNA repair in human medulloblastoma cell lines.

Authors:  Anna Wilk; Agnieszka Waligorska; Piotr Waligorski; Augusto Ochoa; Krzysztof Reiss
Journal:  PLoS One       Date:  2012-03-16       Impact factor: 3.240

Review 6.  Neuronal apoptosis by prolyl hydroxylation: implication in nervous system tumours and the Warburg conundrum.

Authors:  Susanne Schlisio
Journal:  J Cell Mol Med       Date:  2009-08-19       Impact factor: 5.310

7.  Women Neuroscientist Disciples of Pío del Río-Hortega: the Cajal School Spreads in Europe and South America.

Authors:  Cristina Nombela; Emilio Fernández-Egea; Elena Giné; Yulia Worbe; Juan Del Río-Hortega Bereciartu; Fernando de Castro
Journal:  Front Neuroanat       Date:  2021-05-10       Impact factor: 3.856

8.  Nerve growth factor in cancer cell death and survival.

Authors:  Niamh H Molloy; Danielle E Read; Adrienne M Gorman
Journal:  Cancers (Basel)       Date:  2011-02-01       Impact factor: 6.639

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.